ATRC AtriCure Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NASDAQ: ATRC
  4. Earnings
?
Relative Growth: Rel. Growth: 80
Relative Strength: Rel. Strength: 95
Relative Valuation: Rel. Valuation: 18
Relative Profitability: Rel. Profitability: 67

EPS in 2026 (TTM): $0.21

Last Report Period Date: Jun 30, 2026

As of September this year, based on AtriCure's most recent financial report, the company's trailing twelve months EPS is $0.21. During 2025, ATRC reported a per-share earnings of -$0.24, which shows a rise compared to the EPS of -$0.95 recorded in 2024. AtriCure's EPS for the quarterly period ending on Jun 30, 2026 came in at $0.18.

ATRC earnings history

Historical annual and quarterly earnings per share (EPS) data for AtriCure
EPS (TTM)
$0.21
EPS Growth YoY (Quarterly)
238.5%
EPS (Quarterly)
$0.18
EPS Growth (Quarterly)
N/A

The yearly earnings per share during 2025 was -$0.24, a rise of 74.7% compared to -$0.95 recorded in 2024. Over the quarter ending Jun 30, 2026, the earnings per share came in at $0.18, reflecting a 238.5% increase compared to the same quarter a year earlier. As of June 2026, the TTM EPS is $0.21. During 2024, the annual earnings per share was -$0.95, representing a decrease of 43.9% compared to 2023.

ATRC EPS vs price chart

ATRC EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
238.5%
EPS growth YoY
74.7%
EPS growth 3Y avg
N/A
EPS growth 5Y avg
N/A

AtriCure has recorded a growth in earnings per share of 238.5% in the past 12 months (YoY, quarterly).

ATRC Earnings Waterfall

Breakdown of revenue, profit and net income for AtriCure

ATRC Earnings vs Peers

What are the earnings of ATRC compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
BSX Boston Scientific Corp 18.85 55.6% 63.3% N/A
MDT Medtronic Plc 24.83 3.3% 9.8% 6.9%
JNJ Johnson & Johnson 31.9 90.6% 17.7% 14.8%
EW Edwards Lifesciences Corp 51.59 -73.6% -9.2% 6.9%
COO Cooper Companies Inc 59.36 -4.6% -1.2% 9.2%
ATRC AtriCure Inc 249.81 74.7% N/A N/A
TFX Teleflex Incorporated N/A -1,462.4% N/A N/A
STXS Stereotaxis Inc N/A 16.7% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.